Infectious Diseases
Toxic Shock Syndrome
Toxic shock syndrome is a rapidly progressive toxin-mediated shock syndrome from Staphylococcus aureus or group A Streptococcus. Treat suspected disease before surveillance criteria are complete: resuscitate, obtain cultures, remove or debride the source, and provide pathogen-directed antitoxin therapy.
Recognition
Recognize TSS before surveillance criteria are complete
TSS is a clinical emergency, not a diagnosis to defer pending desquamation or microbiologic confirmation.
TSS results from toxin-producing Staphylococcus aureus or Streptococcus pyogenes. Superantigen activity causes broad T-cell activation and cytokine release, producing capillary leak, hypotension, and multiorgan dysfunction. CDC+1CDCSuperantigens and Streptococcal Toxic Shock Syndrome - Volume 9, Number 10—October 2003 - Emerging Infectious Diseases journal - CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf STSS is defined by GAS infection with abrupt shock and organ failure; hypotension generally develops within 24 to 48 hours after initial symptoms. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC
A diffuse rash is helpful but not required for early action. In a pediatric series, 48% of STSS cases lacked rash; delayed use of clindamycin and IVIG was associated with longer hospitalization among children without rash. CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC TSS may arise from a small or occult focus, and blood cultures can be negative in staphylococcal disease. ScienceDirectScienceDirectLesson of the month 2: Toxic shock syndrome
STSS should be especially considered with severe focal pain out of proportion to examination, recent surgery or skin disruption, varicella-associated skin lesions, diabetes, alcohol use disorder, or age 65 years or older. NSAID exposure may increase risk, although evidence is limited. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC
Clinical triggers for immediate escalation: rapidly progressive hypotension; fever or hypothermia; vomiting or diarrhea; myalgias; altered mental status; diffuse erythema or mucosal hyperemia; thrombocytopenia, coagulopathy, kidney injury, liver injury, hypoxemia, or rapidly expanding soft-tissue abnormalities. CDC+2CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Actively inspect for a retained tampon, vaginal device, nasal packing, postoperative wound, abscess, cellulitis, burn, deep soft-tissue infection, or necrotizing infection. ScienceDirect+1ScienceDirectLesson of the month 2: Toxic shock syndromePubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Diagnosis
Order cultures and organ-injury testing while resuscitation proceeds
The diagnostic task is to establish a toxin-mediated syndrome, identify the organism and source, and exclude competing causes of shock.
There is no single diagnostic test for TSS. Obtain blood cultures and cultures from any suspected source before antimicrobials when this does not delay treatment. Evaluate organ involvement with CBC and platelets, comprehensive metabolic panel, creatine kinase, coagulation studies, urinalysis, and assessment for pulmonary involvement. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
For STSS surveillance classification, the CSTE case definition requires hypotension, multiorgan involvement, and GAS isolation; isolation from a sterile site supports a confirmed case. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC These criteria optimize specificity and should not be treated as bedside prerequisites for empiric therapy. CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
Early imaging should be directed by the suspected source and must not postpone exploration when necrotizing soft-tissue infection is plausible. In STSS, severe pain can precede prominent local findings, and bullae or violaceous progression should prompt emergent surgical exploration. CDCCDCStreptococcal Toxic-Shock Syndrome
Obtain immediately: blood cultures; culture or Gram stain of wound, deep tissue, vaginal/cervical, or other implicated source; CBC with differential and platelets; serum creatinine, hepatic tests, bilirubin, electrolytes, CK, lactate, and coagulation studies. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Assess for occult organ dysfunction: urinalysis, chest imaging or oxygenation assessment when respiratory involvement is suspected, and serial evaluation for kidney injury, coagulopathy, hepatic injury, and tissue necrosis. CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
Maintain a broad differential for shock with rash or multisystem disease, including bacterial sepsis, necrotizing soft-tissue infection, rickettsial illness, leptospirosis, measles, Kawasaki disease with shock, and drug reactions. CDC+1CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Management
Resuscitate, control the source, and start antitoxin-active therapy
Early ICU-level care is appropriate when shock or evolving organ failure is present.
Hospitalize patients with suspected STSS. Begin standard shock management with intravenous fluid resuscitation and organ support; add vasopressors when hypotension persists despite fluids. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf Serially reassess hemodynamics, urine output, respiratory failure, renal function, hepatic injury, coagulation abnormalities, and evolving skin or soft-tissue findings. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Source control is time-critical. Remove tampons, packing, or other retained foreign material; drain abscesses; and obtain urgent surgical assessment for suspected deep infection. CDC specifically notes that surgical debridement may be necessary in STSS. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC
For confirmed or strongly suspected STSS, CDC identifies penicillin plus clindamycin as first-line antibiotics. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC Clindamycin is used in combination, not alone, because it suppresses toxin production but is bacteriostatic. PubMedPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf The supplied sources do not provide a U.S. dosing regimen for penicillin or clindamycin; use current institutional severe invasive GAS pathways and adjust to kidney function, allergy history, and microbiology results.
At presentation, use empiric therapy broad enough for MRSA, GAS, and potential polymicrobial soft-tissue infection when the organism and source are uncertain; narrow once cultures and source evaluation clarify the syndrome. PubMedPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
When GAS is identified, transition to penicillin plus clindamycin unless patient-specific contraindications require an alternative. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC
Do not treat antibiotics as a substitute for debridement or removal of an infected device/foreign body. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Role of intravenous immunoglobulin
CDC states that IVIG can be considered early for severely ill patients with STSS, but efficacy has not been proven. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC A pediatric review found variable outcomes with IVIG and no significant difference in measured outcomes among treatment groups in its retrospective cohort. CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC Use should therefore be individualized, generally as an adjunct in severe or refractory toxin-mediated illness after immediate resuscitation, antimicrobials, and source-control planning are underway. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
Document the rationale for IVIG as adjunctive, off-label use in this setting; the supplied sources do not establish an optimal dose. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
Do not delay surgery, vasopressors, or appropriate antimicrobials while arranging IVIG. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Monitoring
Anticipate rapid deterioration and high morbidity
Deterioration can occur within hours, particularly in STSS with deep-tissue infection.
STSS can progress from influenza-like symptoms to hypotension within 24 to 48 hours. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC Organ failure may involve renal, hepatic, respiratory, hematologic, and soft-tissue systems; complications include need for debridement or amputation. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCAbout Streptococcal Toxic Shock Syndrome | Group A Strep | CDC
CDC reports that STSS mortality can exceed 30% despite aggressive treatment and is higher with advancing age. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC In historical clinical descriptions, deep soft-tissue infection commonly required debridement, fasciotomy, or amputation. CDCCDCStreptococcal Toxic-Shock Syndrome
Monitor serial hemodynamics, vasopressor requirement, urine output and creatinine, platelets and coagulation studies, hepatic tests, oxygenation, CK when myositis is suspected, and repeated examination of the implicated soft-tissue compartment. CDC+2CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock SyndromePubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Escalate surgical reassessment for persistent pain, progressive edema/erythema, new bullae, rising CK, or worsening shock despite antimicrobial therapy. CDCCDCStreptococcal Toxic-Shock Syndrome
Reassess microbiology daily and narrow therapy only after source control, cultures, and clinical trajectory support doing so. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
For confirmed invasive GAS, CDC does not routinely recommend antibiotic prophylaxis or routine screening for household contacts; clinicians may consider prophylaxis when household members include persons at increased risk. CDCCDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC
Common questions
Can toxic shock syndrome be diagnosed without rash?
Yes. Rash may be absent early and was absent in 48% of pediatric STSS cases in one series. Absence of rash must not delay resuscitation, cultures, source evaluation, antitoxin-active therapy, or surgical consultation when the clinical syndrome suggests TSS. CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
What is the first-line antibiotic regimen for streptococcal toxic shock syndrome?
CDC identifies penicillin plus clindamycin as first-line therapy for STSS. Use clindamycin in combination rather than alone, and pair antibiotics with immediate resuscitation and source control. The supplied sources do not provide dosing; follow current institutional severe invasive GAS protocols. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
When should surgery be involved?
Immediately when deep soft-tissue infection is possible, especially with severe disproportionate pain, rapidly progressive swelling or erythema, vesicles, bullae, violaceous change, or refractory shock. Debridement may be necessary for STSS and should not await definitive imaging or late cutaneous findings. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock Syndrome
Should IVIG be routinely given for STSS?
No. CDC permits consideration of IVIG early in severely ill STSS, but states that efficacy has not been proven. It should be individualized as adjunctive therapy after core resuscitation, antimicrobial therapy, and source-control planning are underway. CDC+1CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
References
- highlights of prescribing information — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- Colchicine Tablets USP, 0.6 mg These highlights do not include all the information needed to use colchicine safely and effectively. See full prescribing information for COLCHICINE TABLETS. COLCHICINE tablets, USP for oral use Initial U.S. Approval: 1961 — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use colchicine safely and effectively. See full prescribing information for Colchicine Tablets, USP. Colchicine Tablets, USP, for oral use Initial U.S. Approval: 1961 — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use ZOSYN safely and effectively. See full prescribing information for ZOSYN. ZOSYN® (piperacillin and tazobactam) injection, for intravenous use Initial U.S. Approval: 1993 — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- Toxic Shock Syndrome Surveillance in the United States ... — www.acpjournals.org · www.acpjournals.org
- Volume 11 Issue Supplement_1 | Clinical Infectious Diseases — academic.oup.com · academic.oup.com
- Epidemiology of Toxic Shock Syndrome in the United States — academic.oup.com · academic.oup.com
- Tri-State Toxic-Shock Syndrome Study. II. Clinical and ... — academic.oup.com · academic.oup.com
- Recurrent Nonmenstrual Toxic Shock Syndrome — academic.oup.com · academic.oup.com
- Toxic Shock Syndrome Toxin 1 - an overview — www.sciencedirect.com · www.sciencedirect.com
- Lesson of the month 2: Toxic shock syndrome — www.sciencedirect.com · www.sciencedirect.com
- Prognostic factors in patients hospitalised with group A ... — www.sciencedirect.com · www.sciencedirect.com
- Toxic Shock Syndrome - an overview — www.sciencedirect.com · www.sciencedirect.com
- Group A Streptococcal Pharyngitis — www.idsociety.org · www.idsociety.org
- Early and Definitive Diagnosis of Toxic Shock Syndrome by Detection of Marked Expansion of T-Cell-Receptor Vβ2-Positive T Cells - Volume 9, Number 3—March 2003 - Emerging Infectious Diseases journal - CDC — wwwnc.cdc.gov · wwwnc.cdc.gov
- Clinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC — www.cdc.gov · www.cdc.gov
- Streptococcal Toxic-Shock Syndrome — wwwnc.cdc.gov · wwwnc.cdc.gov
- Manifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC — wwwnc.cdc.gov · wwwnc.cdc.gov
- Superantigens and Streptococcal Toxic Shock Syndrome - Volume 9, Number 10—October 2003 - Emerging Infectious Diseases journal - CDC — wwwnc.cdc.gov · wwwnc.cdc.gov
- About Streptococcal Toxic Shock Syndrome | Group A Strep | CDC — www.cdc.gov · www.cdc.gov
- Toxic Shock Syndrome in Patients Younger than 21 Years ... — stacks.cdc.gov · stacks.cdc.gov
- Staphylococcal Toxic Shock Syndrome 2000–2006 — stacks.cdc.gov · stacks.cdc.gov
- The Management of Staphylococcal Toxic Shock Syndrome. A Case Report - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Toxic Shock Syndrome - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov